Page 2 - பயாப்ஸி News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from பயாப்ஸி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In பயாப்ஸி Today - Breaking & Trending Today
Blood Collection Tubes for Liquid Biopsy Sales Set to Grow at 12% through 2021: Fact.MR NEW YORK, March 11, 2021 /PRNewswire/ Fact.MR is conducting an ongoing research study on the blood collection tubes for liquid biopsy market. As per its findings, a positive growth outlook is expected for 2021, primarily underpinned by increasing technological advancements and increasing R&D activities from the government. Growth prospects for the upcoming decade are also optimistic, registering a noteworthy expansion rate until 2031. According to Fact.MR, the market is poised to benefit immensely from the rising usage of CTCs and ctDNA for liquid biopsy applications. According to National Center for Health Statistics, in 2021, 1.8 million new cancer cases are projected to occur in the U.S., surging the sales for blood collection tubes for liquid biopsy. ....
March 8, 2021, 4:58 PM) Ronna Cotton, mammography tech, helps a patient at Diagnostic Imaging -West Houston Cathy Phillips Chelin, a retired nurse from West Houston, found a strange lump in her breast in December. She had a routine mammogram a few months earlier that yielded normal results, but her mind automatically went to the worst. Cathy Phillips Chelin and her husband Hartley. I was thinking and thinking, what could this be? Chelin said. Is it lymphoma? Is it some form of cancer? Her nurse practitioner recommended coming back in for another mammogram and ultrasound. The images again showed no abnormalities in the breast, but several lymph nodes in the left underarm area, also known as the axilla, were unusually large. ....
Patients can spend up to six years waiting for a kidney transplant. Even when they do receive a transplant, up to 20 percent of patients will experience rejection. ....
Researchers confirm a threshold value for non-invasive imaging biomarker Breast cancer is the commonest fatal cancer in women. Early detection increases a woman s chances of recovery. Magnetic Resonance Imaging (MRI) is an accurate technique for detecting and classifying tumors in breast tissue. However, it sometimes causes false alarms , thus requiring further investigation (biopsy) and in some cases even resulting in so-called overtreatment, that is to say, unnecessary surgery. For the first time, a research team from MedUni Vienna has now confirmed a threshold value for a non-invasive imaging biomarker. This can be incorporated into short standard MRI scans and could reduce the biopsy rate following MRI scans by 30%. Since the infrastructure for this measurement already exists in every radiological facility in Austria, the biomarker could be immediately deployed countrywide. ....
Long-term steroid treatment may not be necessary for kidney transplant patients Long-term use of a medication used to treat kidney transplant patients may not be necessary in individuals with low-to-moderate risk of organ rejection, according to the results of a study led by a University of Cincinnati transplant researcher. The randomized clinical trial of 385 patients on immunosuppressive drugs tacrolimus and mycophenolate examined whether use of these medicines called corticosteroids could be eliminated at seven days after kidney transplantation. The study shows that 15 years after transplantation no difference in kidney transplant survival or patient survival rates were found between patients who received long-term corticosteroids versus those who had corticosteroid eliminated early, explains E. Steve Woodle, MD, the William A. Altemeier Endowed Chair and Professor of Surgery in the UC College of Medicine, and leader of the study. ....